Skip to main content
Marcin Imielinski, MD, Pathology, Boston, MA

Marcin B Imielinski MD PhD

Molecular Genetics, Anatomic Pathology, Clinical Pathology


Clinical Fellow in Pathology, Massachusetts General Hospital

Join to View Full Profile
  • 101 Nicolls RdBoston, MA 11794

  • Phone+1 617-726-2967

Are you Dr. Imielinski?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Marcin Imielinski, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and New York. He is a Clinical Fellow in Pathology at Massachusetts General Hospital.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2011 - 2012
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2011
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2015 - 2027
  • MA State Medical License
    MA State Medical License 2014 - 2015
  • Pathology - Clinical
    American Board of Pathology Pathology - Clinical
  • Pathology - Molecular Genetic
    American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Press Mentions

  • Molecular Pathology Selected Abstracts
    Molecular Pathology Selected AbstractsOctober 22nd, 2022
  • Whole Exome Sequencing Predicts Whether Patients Respond to Cancer Immunotherapy
    Whole Exome Sequencing Predicts Whether Patients Respond to Cancer ImmunotherapyJuly 12th, 2022
  • Two Investigators Win Pershing Square Sohn Prize for Cancer Research
    Two Investigators Win Pershing Square Sohn Prize for Cancer ResearchMay 28th, 2021
  • Join now to see all